CSX Announces Departure of Operations Executive Jamie Boychuk
August 04, 2023 08:30 ET
|
CSX Corporation
JACKSONVILLE, Fla., Aug. 04, 2023 (GLOBE NEWSWIRE) -- CSX (NASDAQ: CSX) announced today that Jamie Boychuk, executive vice president of Operations, is leaving the company. President and Chief...
Terrestrial Energy Names Former CEO of TVA and PG&E to Board of Directors
February 28, 2023 09:12 ET
|
Terrestrial Energy Inc.
OAKVILLE, Ontario, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Terrestrial Energy, an advanced nuclear technology company, has appointed William “Bill” Johnson, former President and Chief Executive Officer of...
Joseph R. Hinrichs Appointed President and CEO of CSX
September 15, 2022 07:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., Sept. 15, 2022 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) one of the nation's leading transportation suppliers, today announced that, as part of a planned succession process,...
Gelest Inc. Announces Executive Management Changes
January 10, 2022 13:00 ET
|
Gelest Inc.
MORRISVILLE, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Gelest Inc. today announced that Edward Kimble will be promoted to Executive Vice President and is responsible for the management of the...
Rackspace Technology Announces Participation at Upcoming Investor Conferences
May 24, 2021 18:13 ET
|
Rackspace Technology, Inc.
SAN ANTONIO, May 24, 2021 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (NASDAQ: RXT) today announced that executive management will participate in the following upcoming investor conferences: ...
APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
March 18, 2021 08:11 ET
|
APIE Therapeutics
Cary, NC, March 18, 2021 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by targeting the apelin receptor (APJ),...
Cognition Therapeutics Appoints Industry Veteran Jack Khattar to its Board of Directors
September 09, 2020 08:00 ET
|
Cognition Therapeutics, Inc.
Pittsburgh, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...